Prostaglandin E2 inhibits mast cell–dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor
- 1 November 2015
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 136 (5) , 1232-1239.e1
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- PGE2maintains the tone of the guinea pig trachea through a balance between activation of contractileEP1receptors and relaxantEP2receptorsBritish Journal of Pharmacology, 2013
- PGE2 receptor (EP4) agonists: Potent dilators of human bronchi and future asthma therapy?Pulmonary Pharmacology & Therapeutics, 2012
- Distinct PGE2-responder and non-responder phenotypes in human mast cell populations: “All or nothing” enhancement of antigen-dependent mediator releaseImmunology Letters, 2011
- EP4 receptor as a new target for bronchodilator therapyThorax, 2011
- Prostaglandin E2 Mediates Cough via the EP3 Receptor: Implications for Future Disease TherapyAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Novel site-specific mast cell subpopulations in the human lungThorax, 2009
- COX‐1, and not COX‐2 activity, regulates airway function: relevance to aspirin‐sensitive asthmaThe FASEB Journal, 2008
- Prostaglandin E2 potentiates the immunologically stimulated histamine release from human peripheral blood‐derived mast cells through EP1/EP3 receptorsAllergy, 2006
- Contractile endothelin-B (ETB) receptors in human small bronchiEuropean Respiratory Journal, 1996
- Tryptase and histamine release during aspirin-induced respiratory reactionsJournal of Allergy and Clinical Immunology, 1991